Introduction {#Sec1}
============

Open reconstructive urethroplasty offers a cost-effective treatment modality for urethral strictures with excellent early success rates of 79--95% \[[@CR1]\]. However, long-term results demonstrate that 14--42% of patients require additional treatment for recurrent strictures after primary surgical reconstruction \[[@CR2]\]. Despite this, there are few standardised guidelines for the treatment of urethral stricture recurrence following urethroplasty, with practice varying widely between urologists \[[@CR3]\].

Redo-urethroplasty and direct vision internal urethrotomy (DVIU) are the established techniques. DVIU remains the most commonly utilised initial method, as it offers a minimally invasive approach with fewer technical challenges, and allows endoscopic assessment of the recurrent stricture. Whilst identified as a valuable therapeutic option for short (\< 1 cm) or bulbar recurrent strictures, high failure rates of up to 100% and complications such as bleeding and infection limit its use to older men, those unwilling to undergo an open reconstruction or patients with multiple comorbidities \[[@CR4], [@CR5]\]. Additionally, repeated endoscopic treatment can result in a chronic urethral stricture, requiring redo DVIU and self-dilatation at regular intervals throughout a man's lifetime \[[@CR6]\]. On the contrary, reported success rates of redo-urethroplasty range between 67 and 92% \[[@CR1]\].

There is considerable variation in the treatment of recurrent urethral strictures from different groups and organisations \[[@CR7]\]. Recurrent strictures remain challenging for reconstructive surgeons, as they are often more complex, associated with extensive scarring and poor tissue vascularity. Data suggest that prior endoscopic treatment is an independent risk factor for failure after urethroplasty \[[@CR8]\]. Additionally, numerous urethroplasty techniques have been described in the literature, but there is a paucity of guidelines with regard the optimal choice of procedure for recurrent strictures, based on the stricture aetiology and location. Therefore, this systematic review aims to:Identify the current techniques described in the literature for redo-urethroplasty for recurrent urethral strictures.Evaluate the current evidence base for the effectiveness of different redo-urethroplasty techniques via re-stricture and complication rates.Discuss current follow-up methods following redo-urethroplasty.Suggest treatment options based on the current evidence for recurrent urethral strictures at different locations and of different aetiologies.

Materials and methods {#Sec2}
=====================

This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines \[[@CR9]\]. Additionally, this study was prospectively registered on the PROSPERO database (Registration Number CRD42018088874).

Study eligibility criteria {#Sec3}
--------------------------

Original research articles including randomised controlled trials, case series and cohort studies as well as conference abstracts with sufficient data that described techniques and outcomes of redo-urethroplasty were included in this study.

Abstracts with insufficient information, non-English articles, case reports, paediatric studies or studies utilising female subjects were excluded. Additionally, only patients with at least one failed urethroplasty previously and having undergone a redo-urethroplasty were eligible for analysis.

Information sources and search {#Sec4}
------------------------------

Studies were identified by searching MEDLINE and EMBASE databases from 1945-July 2018. No restrictions with regard to publication status were imposed. The last search was performed on the 22.07.2018. Search terms included a combination of "urethroplasty" and "redo" or "reoperative", which identified the majority of the articles. These results were combined with "hypospadias", "urethral", "panurethral", "treatment failure", "urethra surgery" and technique" to supplement the identified studies. A reference review of identified articles was subsequently carried out. Ongoing clinical trials were searched for grey literature at <http://www.clinicaltrials.gov> with authors of potentially relevant studies contacted for preliminary or unpublished results for inclusion in review.

Study selection {#Sec5}
---------------

The search and study selection were performed independently by two reviewers (SJ and OB) with any discrepancies discussed. The advice of the third reviewer was sought if these could not be resolved. Studies that were identified using the search terms were assessed for further evaluation through abstract review once duplicates were removed. Subsequently, a full text review allowed exclusion of the irrelevant studies.

Data collection and data items {#Sec6}
------------------------------

Data were extracted from all studies onto a pre-defined extraction sheet including the following: author, publication year, surgical technique, number of patients, age of patient, location and length of the stricture, previous treatment, and aetiology of the stricture.

Primary outcome measures to assess the effectiveness specific for each surgical technique included success rate measured as re-stricture rate and post-op maximum urinary flow rate (*Q*~max~). Secondary measures included complication rates, post-operative patient-reported quality of life (assessed through questionnaires and patient-reported symptoms) and follow-up method.

This process was performed by two researchers independently (SJ and OB) and any discrepancies were addressed. Quality Appraisal of Case Series Studies Checklist \[[@CR10]\] was used to assess bias as the case series and case--control studies were the only type of papers identified in this review. This is a 20-item checklist developed and validated by the Institute of Health Economics to be used as a risk of bias assessment tool.

Results {#Sec7}
=======

Study selection {#Sec8}
---------------

A total of 4800 potentially relevant studies were identified. Abstract review and removal of duplications allowed for exclusion of 4661 articles. After review of full-texts, 103 studies were excluded from the analysis. Three articles were added after reference review. The final analysis was conducted on 39 articles (Fig. [1](#Fig1){ref-type="fig"}). Two ongoing clinical trials were identified with no data available for inclusion in review after authors were contacted.Fig. 1PRISMA diagram for study selection

Study characteristics and results synthesis {#Sec9}
-------------------------------------------

Articles included in the review consisted of case series with both retrospective and prospective data analyses. The results were tabulated and the studies were grouped according to the surgical technique used and stricture location. Separate consideration was also given to strictures with a background of hypospadias and trauma. Data extracted from the studies were categorised into the following headings: the success rates of different redo-urethroplasty techniques, the success rates of different sites of stricture, complication rates and follow-up methods following redo-urethroplasty.

Types of procedures and their outcomes {#Sec10}
--------------------------------------

### Anastomotic urethroplasty (AU) {#Sec11}

Twenty-two studies described the use of anastomotic end-to-end urethroplasty in 893 patients (Table [1](#Tab1){ref-type="table"}). AU was used to treat anterior strictures in 32% (*n* = 7) \[[@CR11], [@CR14], [@CR17], [@CR18], [@CR20], [@CR25], [@CR29]\], posterior strictures in 45% (*n* = 10) \[[@CR13], [@CR15], [@CR19], [@CR23], [@CR26], [@CR28]--[@CR30], [@CR45], [@CR46]\] and mixed bulbo-membranous strictures in 14% (*n* = 3) \[[@CR15], [@CR27], [@CR29]\] of the studies which were reviewed. Five studies (*n* = 5) \[[@CR12], [@CR16], [@CR21], [@CR22], [@CR24]\] did not provide information on the location of the stricture. Additionally, over half (*n* = 12) of the studies did not report the mean length of the urethral stricture treated, with only three studies \[[@CR17], [@CR27], [@CR45]\] reporting the mean stricture length specifically for the patients who underwent the anastomotic procedure as 2.1 cm for bulbar, 2.8 cm for membranous and 4.2 cm for bulbo-membranous strictures. The mean follow-up ranged from 4 to 70 months in the studies reviewed. Six studies did not report the exact number of patients undergoing AU.Table 1Articles describing anastomotic urethroplastyArticle first author, publication dateNo. of patientsStricture siteSuccess rateFailure definitionMean follow-up (months)Mean length (cm)Ekerhult et al., 2016 \[[@CR14]\]^a^20Bulbar58% bulbarNeed for surgical instrumentationBulbar 70Bulbar 2Bhagat et al., 2011 \[[@CR15]\]^a^40Bulbo-membranous/membranous/prostato-membranousN/DMaximum urinary flow \< 15 ml/s603.7Gupta et al., 2008 \[[@CR13]\]52Posterior96.20%Maximum urinary flow \< 10 ml/s54N/DLevine et al., 2014 \[[@CR16]\]^a^8N/D88%Urethral patency \< 16Fr494.9Blaschko et al., 2012 \[[@CR12]\]^a^54N/D88%Need for surgical intervention or more than one endoscopic treatment554.4Siegel et al., 2015 \[[@CR17]\]19Bulbar95%N/D30.12.1Barbagli et al., 1996 \[[@CR11]\]^a^2Anterior100%N/D57N/DMorey et al., 1997 \[[@CR18]\]^a^N/DBulbar100%N/D12N/DWadhwa et al., 1998 \[[@CR19]\]^a^14Posterior78.57%Need for surgical instrumentation42Joseph et al., 2002 \[[@CR20]\]^a^N/DBulbar/penile100%N/D60N/DShau et al., 2015 \[[@CR21]\]^a^N/DN/D80%Need for any instrumentation422.7Jakse et al., 1996 \[[@CR22]\]52N/D90.40%N/D45N/DOrabi et al., 2008 \[[@CR23]\]^a^25Posterior97%N/DN/DN/DImbeault et al., 2014 \[[@CR24]\]^a^N/DN/DN/DRadiological abnormality25N/DCavalcanti et al., 2012 \[[@CR25]\]^a^6Bulbar81.80%Need for any instrumentation or *Q*~max~ \< 15 ml/s30.82.8Pardeshi et al., 2016 \[[@CR26]\]21Posterior95.20%Need for instrumentationN/DN/DKulkarni et al., 2015 \[[@CR27]\]15Bulbo-membranous93.30%Need for any instrumentation184.2Patrascoiu et al., 2012 \[[@CR28]\]16Posterior68.70%Need for instrumentation or maximum flow \< 18 ml/s38N/DAndrich et al., 2011 \[[@CR29]\]^a^N/DBulbar/membranous/prostatic100% bulbar, 75% bulbo-prostaticRadiologically abnormal42N/DWebster et al., 1990 \[[@CR30]\]^a^20MembranousN/DNeed for any instrumentationN/DN/DShenfeld OZ, 2004 \[[@CR45]\]8Membranous100%Need for any instrumentation272.8Kulkarni SB, 2018 \[[@CR46]\]^a^541Posterior79.13%N/D68N/D^a^Other techniques also described in the study

Success rates were reported in 19 studies and ranged from 58 to 100% (Table [1](#Tab1){ref-type="table"}). The most commonly used definition for procedural failure was the need for any instrumentation as reported in 32% (*n* = 7) \[[@CR21], [@CR25]--[@CR28], [@CR30], [@CR45]\] of studies. The need for surgical intervention reported in 14% (*n* = 3) \[[@CR12], [@CR14], [@CR19]\] and radiological abnormality reported in 9% (*n* = 2) \[[@CR24], [@CR29]\] of studies represented the next most common definitions. 27% (*n* = 6) of studies did not report the failure definition adopted for the data analysis. However, the definition utilised showed differing success rates. When failure was defined as a need for any instrumentation, success rates ranged from 68.7 to 100%. The need for surgical intervention was associated with success rates of between 58 and 88%. Radiological recurrence rate was reported as 0--25%; however, this is a less useful measure, as re-intervention is also based on patients' symptoms rather than radiological abnormality in isolation.

### One-stage substitution urethroplasty {#Sec12}

Twenty-five studies (768 patients) described the use of one-stage substitution urethroplasty with a variety of grafts and flaps (Table [2](#Tab2){ref-type="table"}). It was used to treat anterior urethral strictures (*n* = 18), posterior strictures (*n* = 5) and panurethral strictures (*n* = 1). Three studies reporting anterior strictures focused on hypospadias cases with 5 studies not discussing the location of the urethroplasty. The mean length of the stricture was reported in six studies with the mean length reported between 4 and 8 cm \[[@CR32]--[@CR34], [@CR39], [@CR41], [@CR43]\].Table 2Articles describing one-stage substitution urethroplastyStudyN. of patientsStricture siteGraft typeGraft placement siteSuccess rateFailure definitionMean follow-up length (months)Mean length (cm)Ekerhult et al., \[[@CR14]\]^a^30PenileBulbarBMG and fasciocutaneousN/DBulbar 58%Penile 18%Need for surgical interventionPenile 82Bulbar 70Penile 4Bulbar 2Rosenbaum et al., \[[@CR31]\]50PenileBulbarBMGBulbar ventral onlay, penile dorsal inlayBulbar 82%Penile 71.4overall 80.8%Need for any instrumentatio*n*/*Q*~max~ rate \< 5 ml/s25.6N/DSevinc et al., \[[@CR32]\]24PenileBulbarfull thickness circumferential skin graft from arm (*n* = 20), inner thigh (*n* = 10) and abdomen (*n* = 4)N/DArm graft 80%, inner thigh 60%, abdomen 50%, overall 69%Need for surgical intervention23.27.7Javali et al., \[[@CR35]\]^a^21PenileBulbarBMGDorsal onlayVentral onlay85.70%Need for any instrumentation42.43.18Pfalzgraf et al., \[[@CR36]\]^a^33PenileBulbarBMG and meshBulbar---ventral onlay, penile---ventral onlay and dorsal onlay, dorsal inlayBulbar 88.2%Penile 68.8%Need for any instrumentation11.8N/DLevine et al., \[[@CR16]\]^a^26PenileBulbarMembranousBMG and penile island flapOnlayNot discussedUrethral patency \< 16 Fr494.9Tang et al., \[[@CR37]\]4PosteriorBMGInlay50%N/DN/DN/DBlaschko et al., \[[@CR12]\]^a^130N/DBMG and faciocutaneousOnlay tubularisedNot discussedNeed for surgical intervention or more than one endoscopic intervention554.4Barbagli et al., \[[@CR11]\]^a^12PenileBulbarFree patchN/D100%N/D57N/DMorey et al., \[[@CR18]\]^a^N/DBulbarBMG, penile skinBMG unknown, penile circular fasciocutaneous flapPatch graft 100%, penile circular rasciocutaneous flap = 79%N/D12N/DWadhwa et al., \[[@CR19]\]^a^1posteriorForearm free flapN/D100%Need for surgical intervention42Zargooshi et al., \[[@CR38]\]12HypospadiasTunica vaginalisCombined onlay tubeNot discussedN/D30N/DXu et al., \[[@CR39]\]56HypospadiasLingual, BMGonlay78.60%Non-functional urethra38.15.6Barbagli et al., \[[@CR40]\]^a^21HypospadiasPenile skin/BMGPenile flaps and dorsal inlay; BMG dorsal inlay/ventral onlayPenile skin 80%, BMG 82%Need for any instrumentation33.8N/DMehrsai et al., \[[@CR41]\]10N/DBMGtubed graft70%Radiological abnormality224.9Joseph et al., \[[@CR20]\]^a^N/DPenileBulbarPanurethralScrotal skin, post-auricular skin, BMGN/DBarbagli patch 100%Orandi flap 75%N/D60N/DMehrsai et al., \[[@CR33]\]34AnteriorPosteriorBMGTubed graft76.50%Need for any instrumentation285.1Shau et al., \[[@CR21]\]^a^N/DBulbar, penileBMG and skin flapsPenile---inlay, Bulbar---onlay75% skin flaps, BMG unknownNeed for any instrumentation422.7Pandey et al., \[[@CR34]\]104AnteriorBMGVentral onlay91.40%N/D548Imbeault et al., \[[@CR24]\]^a^N/DN/DBMG, scrotal skin, lingual graftDorsal/ventralNot discussedRadiological abnormality25N/DAndrich et al., \[[@CR25]\]^a^23BulbarBMGVentral onlay and dorsal onlay, double graft81.80%Need for any instrumentation or*Q*~max~ \< 15 ml/s30.82.8Andrich et al., \[[@CR42]\]^a^40N/DN/DN/DN/DN/D96N/DGrant et al., \[[@CR43]\]39anteriorBMGVentral onlay and dorsal onlay87.20%Urethral patency \< 14 FrN/D4Andrich et al., \[[@CR29]\]^a^N/DBulbarMembranousBMG, scrotal skinBMG unknown, scrotal inlayBulbar BMG 100%, scrotal inlay 60%Radiological abnormality42N/DVetterlein et al., \[[@CR47]\]98 (64 repeat, 34---2^°^Bulbar, penileBMGOnlay, inlayRepeat---87.5%2°---70.8%N/D32N/D^a^Other techniques also described in the study

The total success rate was between 18 and 100%, at a mean follow-up between 4 and 82 months. Data on the success rate were missing from 5 of the studies. The most commonly utilised technique included the use of a buccal mucosal graft (BMG) in 80% of studies (*N* = 20). Three studies utilised a scrotal skin flap (scrotal inlay, Orandi flap, Barbagli patch) \[[@CR20], [@CR24], [@CR29]\], with a further three using a penile skin (penile island flap) \[[@CR16], [@CR18], [@CR40]\]. However, studies utilised a range of graft donor sites including abdominal skin \[[@CR32]\], inner thigh skin \[[@CR32]\], synthetic mesh \[[@CR36]\], arm skin \[[@CR32]\], post-auricular skin \[[@CR20]\], lingual mucosa \[[@CR24], [@CR39]\], tunica vaginalis \[[@CR38]\] and forearm free flap \[[@CR19]\].

BMG grafts provided a success rate of 18--100% when used as a one-stage substitution in thirteen studies \[[@CR11], [@CR14], [@CR25], [@CR29], [@CR31], [@CR33], [@CR34], [@CR36], [@CR37], [@CR41], [@CR43], [@CR47]\]. The most commonly used definition for failure was the need for any instrumentation (28%, *n* = 7) with the success rate ranging from 68.8 to 88.2%. The presence of any radiological abnormality (12%, *n* = 3) provided a success rate of 60--100% with the need for surgical intervention (16%, *n* = 4) a success rate range of 18--100%. Eight studies did not state the definition of failure. The largest cohort investigating BMG urethroplasty was seen in a study by Pandey et al. \[[@CR34]\] which described 104 cases of anterior urethral strictures with a mean length of 8 cm and treated with a BMG ventral onlay urethroplasty with good success rates of 91.4% at 54 months.

Different graft sources provided success rates of 80% for skin grafts from the arm, 60% inner thigh skin graft, 50% for abdominal skin graft as reported by one study by Sevinc et al. \[[@CR32]\] and 60% for scrotal skin graft reported by Andrich et al. \[[@CR29]\].

Moreover, Vetterlein et al. \[[@CR47]\] described success rates of one-stage BMG urethroplasty for anterior strictures in secondary (re-operation using technique different to the one used in primary intervention) and repeat cases (re-operation using the same technique as used in primary intervention). Secondary procedures were successful in 87.5% of cases and secondary cases provided success rates of 70.8%. It was reported that a previous urethroplasty using any technique other than BMG urethroplasty had a significant negative impact on the outcome of the redo procedure.

### Two-stage substitution urethroplasty {#Sec13}

Twelve studies reported on 106 patients who had undergone a two-stage substitution urethroplasty procedure (Table [3](#Tab3){ref-type="table"}). Five studies did not report the exact number of patients treated. It was used to treat anterior strictures in eight studies, posterior strictures in one and panurethral strictures in two studies. Three of the studies describing anterior strictures described only hypospadias cases and two did not report the exact site of the urethral stricture treated. Only one study described a mean stricture length of 8 cm (range 5--14 cm) \[[@CR48]\].Table 3Articles describing two-stage substitution urethroplastyArticle first author, year of publicationN. of patientsStricture siteGraft typeGraft placementSuccess rateFailure definitionMean follow-up length (months)Mean length (cm)Ekerhult et al., 2016 \[[@CR14]\]^a^5PenileBMGN/D20%need for surgical intervention824Javali et al., 2016 \[[@CR35]\]^a^N/DPanurethrallingualBracka techniqueN/DNeed for any instrumentation42.43.18Pfalzgraf et al., 2014 \[[@CR36]\]^a^N/DBulbarPenileBMGN/DN/DNeed for any instrumentation11.8N/DBhagat et al., 2011 \[[@CR15]\]^a^N/DN/DBMGScrotal inlayN/DMaximum urinary flow \< 15 ml/s603.7Barbagli et al., 1996 \[[@CR11]\]^a^3BulbarpenileN/DN/D100%N/D57N/DWadhwa et al., 1998 \[[@CR19]\]^a^3PosteriorN/DN/D100%Need for surgical intervention42Morrison et al., 2018 \[[@CR44]\]^a^27HypospadiasBMGAbdominal skinPost-auricular skinN/D100% for BMGN/D1147Barbagli et al., 2006 \[[@CR40]\]^a^N/DHypospadiasBMG/penile skinN/D50% for penile skin, 82% for BMGNeed for any instrumentation33.8N/DJoseph et al., 2002 \[[@CR20]\]^a^N/DPenileBulbarPanurethralBMG/post-auricular skinN/D78.9% for BMG, unknown for otherN/D60N/DCalvacanti et al., 2012 \[[@CR25]\]^a^4BulbarPenileBMGN/DN/DNeed for instrumentation of maximum urinary flow \< 15 ml/s30.82.8Andrich et al., 2005 \[[@CR42]\]^a^49N/DN/DN/DN/DN/D96N/DMeeks et al., 2009 \[[@CR48]\]15HypospadiasBMG, abdominal skin, penile skin, posterior auricular skinN/D86%Clinical evidence, increased post-void residual volume on USG238^a^Other techniques also described in the study

Eight studies utilised a BMG, with the remaining studies using post-auricular skin (*n* = 3), penile skin (*n* = 2), lingual mucosa (*n* = 1) and abdominal skin (*n* = 2) as a graft source. The total success rate ranged between 20 and 100% at a mean follow-up between 11.8 and 114-months in 12 studies \[[@CR5], [@CR11], [@CR15], [@CR19], [@CR20], [@CR25], [@CR35], [@CR36], [@CR40], [@CR42], [@CR44], [@CR48]\]. Five studies failed to report the success rates specific to this technique. Failure was defined as the need for any instrumentation in 4 (success rate range was 50--82%) and need for surgical intervention in 2 studies (success rate range of 20--100%). One study used clinical evidence and increased post-void residual urine volumes as failure definition; the success rate reported was 86%. Five studies did not define their success rates. Studies consisted of small cohorts with the biggest cohorts reported by Andrich et al. \[[@CR42]\] and Morrison et al. with 49 and 27 cases, respectively \[[@CR44]\].

Stricture location, surgical procedures and their outcomes {#Sec14}
----------------------------------------------------------

Urethral strictures were classified into penile, bulbar, bulbo-prostatic, bulbo-membranous, hypospadias and posterior urethral strictures. Two techniques were described for penile strictures: one-stage and two-stage substitution urethroplasty (stricture length ranged from 1 to 12 cm). The success rates of 18--71.4%, at a mean follow-up of 25.6--82 months, were achieved for penile strictures treated with one-stage BMG urethroplasty in two studies \[[@CR14], [@CR31]\]. Poor success rate of 20% was achieved for two-stage BMG urethroplasty in one study \[[@CR31]\]. Twenty-six articles were excluded from this part of the review due to a lack of site-specific success rate data.

Five studies described redo-urethroplasty as a treatment for recurrent bulbar strictures (stricture length range 1--8 cm). Techniques utilised included end-to-end anastomotic urethroplasty (four studies) and one-stage urethroplasty using a BMG (three studies) and fasciocutaneous penile flap (one study). Patients who received anastomotic urethroplasty achieved success in 58--100% of cases, at a mean follow-up of 12--82 months, as reported by four studies. The success rate of the substitution urethroplasty for bulbar strictures when using a BMG was 58--100%, at a mean follow-up of 25.6--82 months) as described by four studies. One study reported the success rate of 79% at a mean follow-up of 12 months for the penile circular fasciocutaneous flap (Table [4](#Tab4){ref-type="table"}).Table 4The success rates of redo-urethroplasty for different urethral sitesFirst author and date publishedUrethral locationTechnique usedSuccess rate (%)N. of patientsMean follow-up (months)Ekelhult et al., 2016 \[[@CR14]\]PenileOne-stage BMG/fasciocutaneous18n/a82Rosenbaum et., 2016 \[[@CR31]\]PenileOne-stage dorsal inlay BMG71.40n/a25.6Two-stage BMG urethroplasty20n/a25.6Ekelhult et al., 2016 \[[@CR14]\]BulbarAnastomotic urethroplasty58n/a70One-stage BMG58n/a70Siegel et al., 2015 \[[@CR17]\]BulbarAnastomotic urethroplasty951930.5Rosenbaum et., 2016 \[[@CR31]\]BulbarOne-stage ventral onlay BMG82n/a25.6Andrich et al., 2011 \[[@CR29]\]BulbarAnastomotic urethroplasty100n/a42One-stage bulbar BMG100n/a42Morey et al., 1997 \[[@CR18]\]BulbarAnastomotic urethroplasty100n/a12One-stage patch graft100n/a12One-stage penile circular fasciocutaneous flap79n/a12Barbagli et al., 2006 \[[@CR40]\]HypospadiasAnastomotic urethroplasty87n/a33.8One-stage BMG urethroplasty82n/a33.8One-stage penile skin flap80n/a33.8Two-stage penile skin50n/a33.8Two-stage BMG urethroplasty82n/a33.8Meeks et al., 2009 \[[@CR48]\]HypospadiasTwo-stage BMG urethroplasty861223Morrison et al., 2018 \[[@CR44]\]HypospadiasTwo-stage BMG urethroplasty100n/a114Pandey et al., 2017 \[[@CR34]\]AnteriorOne-stage BMG ventral onlay91.4010454Vetterlein et al., 2018 \[[@CR47]\]AnteriorOne-stage BMG urethroplastyRepeat 87.52°---70.8Repeat 642°---3432Kulkarni et al., 2015 \[[@CR27]\]Bulbo-membranousAnastomotic urethroplasty93.301518Orabi et al., 2008 \[[@CR23]\]PosteriorAnastomotic urethroplasty9751n/aPardeshi et al., 2016 \[[@CR26]\]PosteriorAnastomotic urethroplasty95.2021n/aPatrascoiu et al., 2012 \[[@CR28]\]PosteriorAnastomotic urethroplasty68.701638Tang et al., 2011 \[[@CR37]\]Posteriorone-stage BMG inlay504n/aWadhwa et al., 1998 \[[@CR19]\]PosteriorAnastomotic urethroplasty78.57144Forearm free flap10014Two-stage urethroplasty10034Gupta et al., 2008 \[[@CR13]\]PosteriorAnastomotic urethroplasty96.205254Shenfeld et al., 2004 \[[@CR45]\]PosteriorAnastomotic urethroplasty100827Kulkarni et al., 2018 \[[@CR46]\]PosteriorAnastomotic urethroplasty79.1354168Andrich et al., 2011 \[[@CR29]\]Bulbo-prostaticAnastomotic urethroplasty75n/a42Webster et al., 1990 \[[@CR30]\]Bulbo-prostaticAnastomotic urethroplasty9520n/a

Only the end-to-end anastomotic urethroplasty technique was reported for the treatment of bulbo-prostatic and bulbo-membranous urethral strictures in two studies and one study, respectively. Stricture lengths varied between 1.5 and 7 cm for bulbo-prostatic strictures and 1--3 cm for bulbo-membranous strictures. Success rates ranged from 75 to 95% \[[@CR29], [@CR30]\] for bulbo-prostatic strictures and a 93.30% success rate was achieved for bulbo-membranous strictures in a single 15 patient case series \[[@CR27]\].

Additionally, three studies described the success rates for different techniques used to treat the hypospadias-related strictures of the anterior urethra. The highest success rate was achieved for the two-stage BMG urethroplasty (success rates of 82--100% at mean follow-up of 23--114 months) as described by all three studies. Other urethroplasty techniques for hypospadias-related strictures were described by Barbagli et al. \[[@CR40]\]; the anastomotic technique was successful in 87%, followed by one-stage BMG urethroplasty which was successful in 82%, one-stage penile skin urethroplasty with a success rate of 80% and two-stage penile skin urethroplasty with the success rate of only 50%, all at the mean follow-up of 33.8 months. However, as the technique is usually chosen depending on the severity of the stricture, the success rates may be influenced by selection bias which may reduce the importance of these differences in results reported.

Isolated posterior (membranous and prostatic urethra) strictures were treated utilising anastomotic, one-stage and two-stage redo urethroplasties. The anastomotic urethroplasty was reported as having successful outcomes in 68.7--100% of patients in seven studies. Only a single study with a small cohort of 4 cases was utilised for one-stage BMG urethroplasties which was successful in only 50% of cases (2/4 cases). Additionally, Wadhwa et al. \[[@CR19]\] described the forearm flap graft as 100% successful in one patient and the two-stage substitution urethroplasty as 100% successful in three patients at 4 months follow-up.

Complication rates and follow-up method post-redo-urethroplasty {#Sec15}
---------------------------------------------------------------

Twenty-nine studies were included in this part of the analysis and the results are summarised in Table [5](#Tab5){ref-type="table"}. Six studies used only one method for follow-up. These included isolated uroflowmetry in two, standardised questionnaires in one and urethrography in three studies. Most commonly, three methods of follow-up were combined, as reported by eight of the studies. Ten studies used a multitier follow-up approach using questionnaires (study-specific questionnaires or AUA symptom score) or uroflowmetry as an initial screen, with cystoscopy or urethrography only conducted if obstructive symptoms were seen. The cutoff point of maximum urinary flow triggering secondary investigations was set at 12 ml/s in two studies \[[@CR27], [@CR40]\], 14 ml/s in two studies \[[@CR11], [@CR33]\] and 15 ml/s in three studies \[[@CR25], [@CR34], [@CR49]\]. Overall, the most commonly used method of follow-up, both in isolation and as part of multitest approach, was urethrography, as reported in 18 studies.Table 5Complication rates and follow-up method post-redo-urethroplastyFirst author, data of publicationMean follow (months)Follow-up methodMean time to recurrence (months)Complication rateRosenbaum et al., 2016 \[[@CR31]\]25.6Cystourethrography and cystoscopy annually13.816.2% urge incontinence, 10.8% stress incontinenceSevinc et al., 2016 \[[@CR32]\]23.2Primary: uroflowmetry every 3 monthsSecondary: flexible cystoscopy and fluoroscopic imagingN/DAbscess, urethrocutaneous fistulaJavali et al., 2016 \[[@CR35]\]42.4Primary uroflowmetry, post-void residual volume, urine culture and AUA symptom score every 4 months for the first 2 years then every 6 months, secondary: retrograde urethrography and urethroscopy24.4Wound infection in 9.52%, foot neuralgia in 4.76%, epididymo-orchitis in 4.76%, iatrogenic hypospadias meatus in 4.76%Pfalzgraf et al., 2014 \[[@CR36]\]11.8Standardised questionnaireN/DUrinary stress incontinence grade I in 15.2% and grade II in 6.1%, altered glans sensitivity in 24.2%, UTI in 36.1%Bhagat et al., 2011 \[[@CR15]\]60UroflowmetryN/DNot discussedLevine et al., 2014 \[[@CR16]\]49Questionnaire and flexible cystoscopyN/DUTIi 10.2%, chordee 14.3%Blaschko et al., 2012 \[[@CR12]\]55Uroflowmetry, retrograde urethrography, voiding cystourethrography17Not discussedSiegel et al., 2015 \[[@CR17]\]30.5Uroflowmetry, voiding cystourethrography, questionnaireN/DNot discussedBarbagli et al., 1996 \[[@CR11]\]57Primary: uroflowmetry, urine culture, secondary: urethrography, voiding cystourethrography if uroflowmetry \< 14 cc/sN/DNot discussedMorey et al., 1997 \[[@CR18]\]12Primary: questionnaires, secondary: retrograde urethrographyN/DNot discussedWadhwa et al., 1998 \[[@CR19]\]4Voiding cystourethrographyN/DNot discussedZargooshi et al., 2004 \[[@CR38]\]30Retrograde urethrography, cystourethroscopy, uroflowmetry, urethral biopsyN/DNot discussedMorrison et al., 2018 \[[@CR44]\]114Patient-reported symptoms, post-void residual volume50.2Not discussedXu et al., 2016 \[[@CR39]\]38.1UroflowmetryN/DOverall 21.4%: urethrocutaneous fistula and neourethral stricturesBarbagli et al., 2006 \[[@CR40]\]33.8Primary: uroflowmetry, secondary: retrograde urethrography and urethroscopy if max flow \< 12 cc/sN/DNot discussedMehrsai et al., 2005 \[[@CR41]\]22Urethrography3Not discussedJoseph et al., 2002 \[[@CR20]\]60Retrograde urethrography, uroflowmetry, symptoms assessmentN/D3% fistula, 3% wound infection, 12% post-void dribblingMehrsai et al., 2007 \[[@CR33]\]28Primary: antegrade cystourethrography, questionnaires, urinalysis and culture, secondary: ultrasonography and cystourethrography if max flow \< 14 cc/s5.5Fistula in 5.88%, erectile dysfunction in 2.94%, diverticulum in 2.94%, cheek swelling and perioral numbness in 17.6%, perioral wound infection 1.8%, UTI 23.5%Shau et al., 2015 \[[@CR21]\]42Primary: uroflowmetry, post-void residual volume, secondary: retrograde urethrographyN/DChronic leg pain 5%Jakse et al., 1996 \[[@CR22]\]45Patient-reported symptoms, clinical examination, urinalysis, uroflowmetry, voiding urethrographyN/DOverall 9%: abscess, haematoma, wound infection, scrotal haematoma, epididymitis, temporary peroneal nerve palsy, incontinencePandey et al., 2017 \[[@CR34]\]54Primary: questionnaire, post-void urine Volume, uroflowmetry, secondary: cystoscopy if max flow \< 15 cc/sN/DNot discussedImbeault et al., 2014 \[[@CR24]\]25Uroflowmetry, urethrography3Not discussedCalvalcanti et al., 2012 \[[@CR25]\]30.8Primary: uroflowmetry, secondary: urethrography, cystoscopy if max flow \< 15 cc/sN/DErectile dysfunction in 15.2%, ejaculatory symptoms in 21.2%Kulkarni et al., 2015 \[[@CR27]\]18Primary: uroflowmetry, urine culture, secondary: urethrography and urethroscopy if max flow \< 12 cc/s2Not discussedPatrascoiu et al., 2012 \[[@CR28]\]38Clinical examination, post-void residual volume, uroflowmetry, urethrographyN/DEpididymo-orchitis 18.75%, wound infection 12.5%, perinea haematoma in 12.5%, de novo erectile dysfunction in 6.25%Andrich et al., 2011 \[[@CR29]\]42UrethrographyN/DNot discussedShenfeld et al., 2004 \[[@CR45]\]27Urethrography (after 1 month), flexible retrograde urethroscopy (after year), uroflowmetry, post-void residual volumeN/DUTI, bladder stones formationdecreased erectile function in 12.5%, mild urinary incontinence in 12.5%Myers et al., 2012 \[[@CR49]\]89Primary: uroflowmetry, voiding cystourethrography; secondary: fluoroscopic imaging if urinary flow \< 15 cc/sN/DNot discussedMeeks et al., 2009 \[[@CR48]\]23Clinical evidence, post-void residual volumeN/DMinor voiding symptoms in 21%, fistula in 7%, mild dysuria in 21%, UTI 14%, BMG oral complications in 7%

Only four studies described details of the frequency of the follow-up regime. Uroflowmetry frequency varied at between 3 and 6 months in two studies \[[@CR32], [@CR35]\], with urethrography used one month post-operatively \[[@CR45]\] and annually \[[@CR31]\]. Average length of follow-up varied widely across studies between 4 and 114 months. The longest follow-up was 9.5 years reported by Morrison et al. \[[@CR44]\]. Seven studies were followed up for less than 1 year, 14 for between 1 and 2 years, 6 for 2--3 years and 2 extended it to over 3 years. The most common complications described for each urethroplasty technique are summarised in Table [6](#Tab6){ref-type="table"}.Table 6Procedure-specific complication rates post-redo-urethroplastyAnastomotic urethroplastyOne-stage substitution urethroplastyTwo-stage substitution urethroplastyDe novo erectile dysfunction 12.5--18.75% \[[@CR22], [@CR28], [@CR45]\]UTI (36.1%) \[[@CR36]\]Voiding symptoms and mild dysuria (21%) \[[@CR48]\]Urinary incontinence (12.5%) \[[@CR28], [@CR45]\]Altered glans sensitivity (24.2%) \[[@CR36]\]UTI (14%) \[[@CR48]\]Perineal haematoma (12.5%) \[[@CR28], [@CR45]\]Cheek swelling and perioral numbness (17.6%) \[[@CR33]\]BMG oral complications (7%)

Eight studies described the mean time to recurrence of urethral stricture after redo surgery with ranges from two to 50.2 months \[[@CR12], [@CR24], [@CR27], [@CR31], [@CR33], [@CR35], [@CR41], [@CR44]\]. Six of these studies reported mean time to recurrence of less than 24 months \[[@CR12], [@CR24], [@CR27], [@CR31], [@CR33], [@CR41]\].

Discussion {#Sec16}
==========

Recurrent urethral strictures are a surgical challenge due to the increased complexity of the strictures due to scarring and poor tissue vascularity. Whilst DVIU offers a less invasive initial treatment modality, it is associated with a high recurrence rate. This systematic review offers an overview of the current evidence for redo-urethroplasty in recurrent strictures, comparing the outcomes using different surgical techniques and according to varying stricture location.

The evidence for the use of anastomotic end-to-end urethroplasty has been assessed in 22 studies. Overall success rates vary widely across studies at 0--100%. When assessing its use to specific locations, anastomotic urethroplasty fared best when utilised in anterior bulbar and posterior recurrent strictures \[[@CR11], [@CR13], [@CR14], [@CR17]--[@CR20], [@CR23], [@CR25], [@CR27]--[@CR29], [@CR45], [@CR46]\]. The success rates were reported as 58--100% and 68.7--100%, respectively, for these cohorts of patients, with four studies reporting success rates of 100% in anterior bulbar strictures.

The success rates for these stricture locations were reported as 75--95% \[[@CR29], [@CR30]\] and 93.30% \[[@CR27]\], respectively.

The evidence for the use of one-stage substitution urethroplasty has been assessed in 25 studies. The overall success rate varied across the studies at 18--100%. The best results were obtained using the substitution urethroplasty technique for bulbar \[[@CR14], [@CR18], [@CR25], [@CR29], [@CR31], [@CR35], [@CR36], [@CR47]\] and hypospadias-related strictures \[[@CR39], [@CR40]\]. The success rates were reported at 58--100% and 78.6--82%, respectively, for these cohorts, with two studies reporting success rates of 100% in bulbar strictures. Conversely, the poorest outcomes were identified for posterior strictures with a success rate of only 50%; however, this consisted of a single four-patient study \[[@CR37]\]. Studies assessing both penile and bulbar urethral strictures \[[@CR14], [@CR31], [@CR36]\] achieved better results for the bulbar strictures with success rates of 18--71.40% and 58--88.2%, respectively. The BMG demonstrated the best evidence base as a graft source for more complex stricture recurrences when compared with penile fasciocutaneous flap \[[@CR18]\] and scrotal skin \[[@CR29]\], with 10 studies reporting success rates of over 80% \[[@CR18], [@CR25], [@CR29], [@CR31], [@CR35]--[@CR37], [@CR40], [@CR43], [@CR47]\]. One-stage BMG urethroplasty was the most successful technique of all to treat penile strictures with a success rates of 71.40% \[[@CR31]\].

Overall 12 studies assessed the use of two-stage substitution urethroplasty. The overall success rate varied across the studies at 20--100%, with the best results obtained in hypospadias-related and posterior strictures. The success rates were reported at 82--100% \[[@CR40], [@CR44], [@CR48]\] and 100% \[[@CR19]\], respectively, for these cohorts. However, the evidence for its use in posterior strictures is limited by a single small cohort study of three patients with a median stricture length of only 2 cm. On the contrary, this technique demonstrated the poorest outcomes in penile strictures with a success rate of 20% (mean stricture length 4 cm) \[[@CR14]\]. However, results were quoted only for a small cohort consisting of five patients. The BMG was reported as a graft with the best evidence for two-stage substitution procedures and was superior to penile skin flap \[[@CR40]\], with 3 studies reporting success rates of over 80% \[[@CR40], [@CR44], [@CR48]\].

Based on the current best evidence and current guidelines identified, we have produced a suggested treatment algorithm for the management of recurrent urethral strictures (Fig. [2](#Fig2){ref-type="fig"}). Whilst the current evidence has demonstrated trends for treatment modalities according to the stricture location, it is important to consider that the identified evidence is limited in several factors.Fig. 2Summary of the most effective redo-urethroplasty techniques identified according to the stricture location

All studies identified were level 4 evidence via case series or case--control studies only, with no randomised controlled studies identified. Furthermore, study cohorts were often retrospective and had limited follow-up with only 15 studies reporting over 40 participants. Formal risk of bias assessment conducted with use of the Quality Appraisal of Case Series Studies Checklist demonstrated that the majority of studies were prone to bias secondary to poor reporting on statistics and design. Most studies were single-centre retrospective case series with no formal statistical assessment, due to the small population size. Additionally, there was considerable study heterogeneity with broad aetiology inclusion criteria, with varying previous interventions and definitions of failures (Supplementary Table 1). Therefore, with this in mind it is important to consider the limitations of current trends in treatment and the widespread applicability of these results.

Finally, the choice of operation is based on the severity of the stricture. Single-stage procedures may be chosen for simple strictures, whereas more complex ones may be treated with two-stage surgery. This selection bias makes it virtually impossible to compare outcomes.

Understanding common complications for differing redo-urethroplasty techniques allows for patient-specific discussions pre-operatively (Table [6](#Tab6){ref-type="table"}). The current literature demonstrates that common complications following end-to-end anastomotic urethroplasty include erectile dysfunction, urinary incontinence and perineal haematoma. When considering one-stage BMG urethroplasty, postoperative UTI, altered glans sensitivity, and complications of graft harvesting including cheek swelling and perioral numbness were the most common complications described. When using other graft sources, urethrocutaneous fistula and abscess formation were seen to be more common. Finally, two-stage BMG urethroplasty was most commonly complicated by voiding symptoms, dysuria, BMG oral complications and fistula formation.

Stricture recurrence was seen at less than 24 months in six out of eight studies in this review, with the longest time to recurrence of 50.2 months. Therefore, a standardised follow-up regime is required with an emphasis on this high-risk timeframe. Whilst the most cost-effective approach is difficult to establish from the current literature, previous evidence from a systematic review suggests a two-tier system to diagnose stricture recurrence \[[@CR50]\]. A possible initial screening protocol could consist of the AUA-SS at every post-op visit, with flexible cystoscopy used as a second tier procedure if the obstructive symptoms are identified. Frequency of follow-up could be implemented on a 3-monthly basis initially with yearly follow-up after the first year (at 0 M, 3 M, 6 M, 9 M, 12 M and 24 M).

Current evidence is reliant on level 4 studies. Therefore, it is clear that further work is required. Whilst technically difficult to conduct due to the variability in surgical technique for individual strictures, more randomised controlled and standardised studies are required. There is a need for prospective data comparing the success rates of specific procedures at different stricture locations, utilising standardised definitions of success rates. This should additionally be compared to less invasive techniques such as DVIU. Strict inclusion criteria with regard to previous intervention and definitions of failure are needed. This will ensure that the future management decisions are patient-specific and based on the objective evidence rather than an institution preference.

We present the second systematic review on the outcomes of redo-urethroplasty, with a previous review of five studies, including paediatric cases conducted \[[@CR51]\]. Success rates of between 35 and 85% out of a total of 212 redo-urethroplasty cases were identified. Through a broader search and inclusion criteria, we have been able to identify numerous further studies and, despite current paucity in high quality studies, are able to discuss trends in the evidence, with potential specific treatment modalities for strictures at different urethral sites. However, this review is not without its limitations. As mentioned previously, it is limited by the quality of the studies identified, with large heterogeneity and small cohort sizes meaning that results may not be applicable to all individual cases and no significant statistical pooling of results could be conducted. Additionally, this is a narrative systematic literature review leading to expert opinion. With all these limitations in mind, no definite conclusions may be drawn from the results. Even though the trends identified by this review are based on the best evidence available, we are uncertain whether suggested treatment modalities for different strictures guarantee the best possible outcomes.

Conclusions {#Sec17}
===========

The success rates of redo surgery after failed urethroplasty are comparable to primary surgery when the appropriate technique is used. This review identified the possible optimal urethroplasty technique for different urethral stricture locations based on the limited current evidence in the literature. Anastomotic urethroplasty fared best when utilised in bulbar and posterior strictures. Substitution urethroplasty was most successful when BMG was used as a graft source. The best results for one-stage BMG urethroplasty were achieved when treating bulbar and hypospadias-related strictures. Multistage BMG urethroplasty was the most successful technique for hypospadias-related and posterior strictures. Redo-urethroplasty treatment and the follow-up pathway algorithm were designed based on the current evidence and existing guidelines. However, the use of Quality Appraisal of Case Series Studies Checklist revealed high risk of bias in the poor quality of studies identified in this review. Thus, we are uncertain whether the trends discussed are the most effective interventions for management of redo urethral strictures. This review highlights the limited current evidence with small cohorts demonstrating the need for further investigation in this difficult to manage group of patients.
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